Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1K08DK114563-01)
American Gastroenterological Association (Research Scholars Award)
Received: 27 June 2019
Accepted: 14 August 2019
First Online: 22 August 2019
Ethics approval and consent to participate
: Patient records were accessed and analyzed through a protocol approved by the Partners Institutional Review Board that waved patient consent.
: J.V.C. has received consulting fees from Sanofi-Genzyme. P.K.B. receives consulting fees from Lilly, Angiochem, Tesaro, Genentech-Roche, speaker’s honoraria from Genentech-Roche and Merck and grant funding from Merck and BMS (institutional). A.R.P. is a consultant/advisory board member for Puretech, Driver, Foundation Medicine and Eisai; and has institutional research funding from Array, Plexxikon, Guardant, BMS, MacroGenics, Genentech-Roche, Novartis, OncoMed, and Tolero. T.S.H. receives research funding (Clinical Trials) from BMS, Taiho, Tesaro, IntraOp, Astra-Zeneca, and Novartis, and an advisory board honorarium from Merck. M.D. receives research funding from Novartis, and has received consulting fees from Genentech-Roche and Tillotts. All other authors declare no competing interests.